Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medicure (MCUJF) EBIT (2016 - 2025)

Historic EBIT for Medicure (MCUJF) over the last 17 years, with Q3 2025 value amounting to $645818.5.

  • Medicure's EBIT rose 17614.5% to $645818.5 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 1612.62%. This contributed to the annual value of $3.8 million for FY2024, which is 3141.98% down from last year.
  • As of Q3 2025, Medicure's EBIT stood at $645818.5, which was up 17614.5% from -$504477.0 recorded in Q2 2025.
  • Medicure's 5-year EBIT high stood at $4.6 million for Q4 2023, and its period low was -$848142.8 during Q3 2024.
  • For the 5-year period, Medicure's EBIT averaged around $990916.0, with its median value being $243435.9 (2023).
  • Per our database at Business Quant, Medicure's EBIT soared by 112748.59% in 2021 and then tumbled by 171870.69% in 2025.
  • Medicure's EBIT (Quarter) stood at $2.2 million in 2021, then surged by 83.69% to $4.0 million in 2022, then increased by 14.29% to $4.6 million in 2023, then fell by 18.67% to $3.7 million in 2024, then crashed by 82.58% to $645818.5 in 2025.
  • Its EBIT stands at $645818.5 for Q3 2025, versus -$504477.0 for Q2 2025 and -$456480.3 for Q1 2025.